← Leaderboards
Anand Ramamurthi
Medical University Of South Carolina
$5,125,841
Attributed
$6,177,832
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $704K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,177,832 · 11
By mechanism
R01$4,055,381 · 3
R21$1,712,540 · 4
R56$396,250 · 1
M01$13,661 · 3
Top collaborators
- Margot S. Damaser8 shared
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Hainan Lang$8,769,721
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsTissuesExtracellular MatrixElastinRepairedHomeostasisAdultCrosslinkFutureStructureRegenerativeOperative Surgical ProceduresFiberDoseStretchingElastic FiberBaseDepositionCell Culture TechniquesNatural RegenerationProtein-Lysine 6-OxidaseSmooth Muscle MyocytesDensityNanoparticle
Grant awards (25)
Matrix Regenerative Nanotherapeutic Platform for Pelvic Organ Prolapse$688,436
R01 · FY2025 · HD
Matrix regenerative nanotherapeutics for small abdominal aortic aneurysm repair$362,250
R01 · FY2021 · HL · contact PI
Matrix Regenerative Nanotherapeutics for Small Abdominal Aortic Aneurysm Repair$401,042
R01 · FY2020 · HL · contact PI
Multimodal nanotherapy to improve surgical mesh outcomes in organ prolapse$200,625
R21 · FY2020 · HD
Matrix Regenerative Nanotherapeutics for Small Abdominal Aortic Aneurysm Repair$400,000
R01 · FY2019 · HL · contact PI
Multimodal nanotherapy to improve surgical mesh outcomes in organ prolapse$240,000
R21 · FY2019 · HD · contact PI
Matrix Regenerative Nanotherapeutics for Small Abdominal Aortic Aneurysm Repair$400,000
R01 · FY2018 · HL · contact PI
Regenerative nanotherapeutics for tissue repair in proteolytic disorders$200,000
R21 · FY2018 · HD · contact PI
Regenerative nanotherapeutics for tissue repair in proteolytic disorders$104,000
R21 · FY2018 · HD · contact PI
Regenerative nanotherapeutics for tissue repair in proteolytic disorders$240,000
R21 · FY2017 · HD · contact PI
Regenerative nanopharmacotherapy for small abdominal aortic aneurysms$396,250
R56 · FY2016 · HL · contact PI
Regenerative Therapy for Pelvic Organ Prolapse$193,171
R21 · FY2015 · HD
Regenerative Therapy for Pelvic Organ Prolapse$237,750
R21 · FY2014 · HD
Cues for cell-mediated regeneration of elastin matrix in aortic aneurysms$455,257
R01 · FY2012 · HL · contact PI
Cues for cell-mediated regeneration of elastin matrix to stabilize aortic aneurys$457,789
R01 · FY2011 · HL · contact PI
Cues for cell-mediated regeneration of elastin matrix to stabilize aortic aneurys$323,747
R01 · FY2010 · HL · contact PI
Cues for cell-mediated regeneration of elastin matrix to stabilize aortic aneurys$49,576
R01 · FY2010 · HL · contact PI
Cues for cell-mediated regeneration of elastin matrix to stabilize aortic aneurys$380,492
R01 · FY2009 · HL · contact PI
Cues for cell-mediated regeneration of elastin matrix to stabilize aortic aneurys$102,379
R01 · FY2009 · HL · contact PI
Cues for cell-mediated regeneration of elastin matrix to stabilize aortic aneurys$34,413
R01 · FY2009 · HL · contact PI
Hyaluronan Scaffold for Regenerating Elastin Matrices$152,244
R21 · FY2008 · EB · contact PI
Hyaluronan Scaffold for Regenerating Elastin Matrices$144,750
R21 · FY2007 · EB · contact PI
TESTING INFLAMMATORY POTENTIAL OF HYALURONAN-DERIVED VASCULAR IMPLANTS$2,022
M01 · FY2007 · RR · contact PI
HYLAN GEL BARRIERS TO PREVENT RESTENOSIS IN ARTERIES$9,801
M01 · FY2005 · RR
TESTING INFLAMMATORY POTENTIAL OF HYALURONAN-DERIVED VASCULAR IMPLANTS$1,838
M01 · FY2005 · RR